Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study
- PMID: 1282104
- DOI: 10.1016/0014-2999(92)90292-c
Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study
Erratum in
- Eur J Pharmacol 1993 Mar 2;232(2-3):326
Abstract
The effects of systemic administration of fluvoxamine on extracellular serotonin (5-hydroxytryptamine, 5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) concentrations in the frontal cortex and raphe nuclei of freely moving rats were examined. Fluvoxamine significantly increased extracellular 5-HT concentrations in both regions at the two doses used (1 and 10 mg/kg i.p.). However, the increase in the raphe nuclei was several-fold that in the frontal cortex. Dialysate 5-HIAA concentrations decreased after treatment with fluvoxamine. These results confirm that 5-HT uptake inhibitors preferentially increase extracellular concentrations of 5-HT in the vicinity of cell bodies and dendrites of serotonergic neurones.
Similar articles
-
Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study.Naunyn Schmiedebergs Arch Pharmacol. 1991 Mar;343(3):237-44. doi: 10.1007/BF00251121. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1714040
-
Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei.Synapse. 1993 Nov;15(3):243-5. doi: 10.1002/syn.890150310. Synapse. 1993. PMID: 7506449 No abstract available.
-
Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat.Naunyn Schmiedebergs Arch Pharmacol. 1993 Jun;347(6):583-90. doi: 10.1007/BF00166940. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 7689703
-
Effects of single and chronic treatment with tranylcypromine on extracellular serotonin in rat brain.Eur J Pharmacol. 1994 Oct 3;263(3):227-34. doi: 10.1016/0014-2999(94)90717-x. Eur J Pharmacol. 1994. PMID: 7531152
-
The effects of brofaromine, a reversible MAO-A inhibitor, on extracellular serotonin in the raphe nuclei and frontal cortex of freely moving rats.J Neural Transm Suppl. 1994;41:357-63. doi: 10.1007/978-3-7091-9324-2_47. J Neural Transm Suppl. 1994. PMID: 7931251
Cited by
-
Subanesthetic doses of ketamine transiently decrease serotonin transporter activity: a PET study in conscious monkeys.Neuropsychopharmacology. 2013 Dec;38(13):2666-74. doi: 10.1038/npp.2013.176. Epub 2013 Jul 24. Neuropsychopharmacology. 2013. PMID: 23880871 Free PMC article.
-
The therapeutic role of 5-HT1A and 5-HT2A receptors in depression.J Psychiatry Neurosci. 2004 Jul;29(4):252-65. J Psychiatry Neurosci. 2004. PMID: 15309042 Free PMC article. Review.
-
Alterations in serotonin transporter and body image-related cognition in anorexia nervosa.Neuroimage Clin. 2019;23:101928. doi: 10.1016/j.nicl.2019.101928. Epub 2019 Jul 3. Neuroimage Clin. 2019. PMID: 31491815 Free PMC article.
-
Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release.Br J Pharmacol. 2010 Dec;161(7):1527-41. doi: 10.1111/j.1476-5381.2010.00978.x. Br J Pharmacol. 2010. PMID: 20698856 Free PMC article.
-
Acute treatment with fluvoxamine elevates rat brain serotonin synthesis in some terminal regions: an autoradiographic study.Nucl Med Biol. 2012 Oct;39(7):1053-7. doi: 10.1016/j.nucmedbio.2012.04.001. Epub 2012 May 5. Nucl Med Biol. 2012. PMID: 22560971 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources